Total Holdings
70
Portfolio diversification across 70 positions
BBP
(NYSEARCA)Virtus Biotech ETF
$95.28-- (--)
Loading... - Market loading
BBP ETF Holdings: Virtus Biotech ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$91.50M
Total fund assets
Expense Ratio
0.34%
Annual management fee
Fund Issuer
Virtus Investment Partners
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | N NK | NantKwest Inc | Stock | 5.08% |
| 2 |  | Moderna, Inc | Stock | 2.55% |
| 3 | A APLS | Apellis Pharmaceuticals, Inc | Stock | 2.51% |
| 4 |  | Iovance Biotherapeutics, Inc | Stock | 2.49% |
| 5 |  | Mirum Pharmaceuticals Inc | Stock | 2.45% |
| 6 | K KALV | Kalvista Pharmaceuticals Inc | Stock | 2.44% |
| 7 |  | Axsome Therapeutics, Inc | Stock | 2.30% |
| 8 |  | Novavax, Inc | Stock | 2.17% |
| 9 |  | TG Therapeutics, Inc | Stock | 2.12% |
| 10 |  | Legend Biotech Corporation | Stock | 1.98% |
| 11 |  | Roivant Sciences Ltd | Stock | 1.98% |
| 12 |  | Travere Therapeutics Inc | Stock | 1.89% |
| 13 |  | Krystal Biotech, Inc | Stock | 1.87% |
| 14 |  | BioCryst Pharmaceuticals Inc | Stock | 1.82% |
| 15 |  | United Therapeutics Corporation | Stock | 1.78% |
| 16 |  | Exelixis, Inc | Stock | 1.75% |
| 17 |  | Ardelyx, Inc | Stock | 1.74% |
| 18 |  | Gilead Sciences, Inc | Stock | 1.72% |
| 19 |  | Zai Lab Limited | Stock | 1.72% |
| 20 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.72% |
| 21 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.71% |
| 22 |  | Biogen Inc | Stock | 1.70% |
| 23 |  | Geron Corporation | Stock | 1.66% |
| 24 |  | Halozyme Therapeutics, Inc | Stock | 1.62% |
| 25 |  | Amgen Inc | Stock | 1.60% |
| 26 |  | Agios Pharmaceuticals, Inc. | Stock | 1.59% |
| 27 |  | Omeros Corporation | Stock | 1.59% |
| 28 |  | Incyte Corporation | Stock | 1.58% |
| 29 |  | Cytokinetics, Incorporated | Stock | 1.57% |
| 30 |  | Precigen, Inc. | Stock | 1.57% |
| 31 |  | BioMarin Pharmaceutical Inc | Stock | 1.57% |
| 32 |  | Ascendis Pharma A/S | Stock | 1.56% |
| 33 |  | Syndax Pharmaceuticals Inc | Stock | 1.56% |
| 34 |  | Arcutis Biotherapeutics, Inc. | Stock | 1.55% |
| 35 | B BGNE | BeiGene, Ltd | Stock | 1.53% |
| 36 |  | ADMA Biologics, Inc. | Stock | 1.53% |
| 37 |  | CRISPR Therapeutics AG | Stock | 1.53% |
| 38 |  | Madrigal Pharmaceuticals, Inc. | Stock | 1.53% |
| 39 |  | Nuvation Bio Inc. | Stock | 1.53% |
| 40 |  | Kura Oncology, Inc. | Stock | 1.52% |
| 41 |  | BioNTech SE | Stock | 1.52% |
| 42 |  | Neurocrine Biosciences, Inc | Stock | 1.51% |
| 43 |  | Sarepta Therapeutics, Inc. | Stock | 1.51% |
| 44 |  | Ultragenyx Pharmaceutical Inc. | Stock | 1.50% |
| 45 |  | Aurinia Pharmaceuticals Inc. | Stock | 1.50% |
| 46 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.49% |
| 47 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.48% |
| 48 |  | Ionis Pharmaceuticals, Inc | Stock | 1.45% |
| 49 |  | Theravance Biopharma Inc | Stock | 1.45% |
| 50 |  | BridgeBio Pharma, Inc | Stock | 1.39% |
Frequently Asked Questions About Virtus Biotech ETF Holdings
What are the top holdings in BBP?
Virtus Biotech ETF (BBP) holds 70 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BBP's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BBP's holdings table to analyze concentration risk.
What is BBP's sector allocation?
The Sector Allocation chart shows how BBP distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BBP invest in?
BBP's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BBP ETF?
BBP's diversification can be assessed by reviewing its 70 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.